These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 15857400
1. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons. Iwakura Y, Piao YS, Mizuno M, Takei N, Kakita A, Takahashi H, Nawa H. J Neurochem; 2005 May; 93(4):974-83. PubMed ID: 15857400 [Abstract] [Full Text] [Related]
2. Heparin-binding epidermal growth factor-like growth factor: a component in chromaffin granules which promotes the survival of nigrostriatal dopaminergic neurones in vitro and in vivo. Hanke M, Farkas LM, Jakob M, Ries R, Pohl J, Sullivan AM. Neuroscience; 2004 May; 124(4):757-66. PubMed ID: 15026116 [Abstract] [Full Text] [Related]
3. Qualitative and quantitative re-evaluation of epidermal growth factor-ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target-derived neurotrophic signaling (Part 1). Iwakura Y, Zheng Y, Sibilia M, Abe Y, Piao YS, Yokomaku D, Wang R, Ishizuka Y, Takei N, Nawa H. J Neurochem; 2011 Jul; 118(1):45-56. PubMed ID: 21517852 [Abstract] [Full Text] [Related]
4. Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Futamura T, Toyooka K, Iritani S, Niizato K, Nakamura R, Tsuchiya K, Someya T, Kakita A, Takahashi H, Nawa H. Mol Psychiatry; 2002 Jul; 7(7):673-82. PubMed ID: 12192610 [Abstract] [Full Text] [Related]
5. Differential distributions of peptides in the epidermal growth factor family and phosphorylation of ErbB 1 receptor in adult rat brain. Piao YS, Iwakura Y, Takei N, Nawa H. Neurosci Lett; 2005 Dec 16; 390(1):21-4. PubMed ID: 16129559 [Abstract] [Full Text] [Related]
6. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain. Chadi G, Silva C, Maximino JR, Fuxe K, da Silva GO. Brain Res; 2008 Jan 23; 1190():23-38. PubMed ID: 18086466 [Abstract] [Full Text] [Related]
14. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease. Reglodi D, Lubics A, Tamás A, Szalontay L, Lengvári I. Behav Brain Res; 2004 May 05; 151(1-2):303-12. PubMed ID: 15084446 [Abstract] [Full Text] [Related]